The global Multiplex Assays Market is projected to reach USD 4.3 billion by 2026 from USD 3.0 billion in 2021, at a CAGR of 7.6%

Ads

You May Also Like

Tetra Bio-Pharma Adds New Marketing Vice-President

ORLEANS, Ontario, Aug. 30, 2018 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc., a leader in ...

Vystar Debuts Enhanced RxAir® UV Light Air Purifiers to Fight Flu, Colds & Airborne Germs

Features longer-lasting, more effective UV light for more efficient inactivation of viruses and bacteriaRxAir ...

XOMA Reports Third Quarter 2016 Achievements and Financial Results

BERKELEY, Calif., Nov. 09, 2016 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq:XOMA), a leader in ...